N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors
申请人:Jones Philip
公开号:US20070155744A1
公开(公告)日:2007-07-05
N-Benzyl-dihydroxypyridine carboxamide compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dihydroxypyridine carboxamides are of Formula (I) wherein Q is Formula (II) or Formula (III); T is Formula (IV); and R
1
, R
2
, X
1
,X
2
,X
3
, and Y
1
are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
N-苄基二羟基吡啶羧酰胺化合物是HIV整合酶的抑制剂,也是HIV复制的抑制剂。在一种实施例中,二羟基吡啶羧酰胺为式(I)中的化合物,其中Q为式(II)或式(III);T为式(IV);R1、R2、X1、X2、X3和Y1在此处定义。这些化合物对预防和治疗HIV感染以及预防、延迟发病和治疗艾滋病具有用处。这些化合物可作为化合物本身或作为药学上可接受的盐的形式用于抗击HIV感染和艾滋病。这些化合物及其盐可作为药物组成部分,可选择地与其他抗病毒药物、免疫调节剂、抗生素或疫苗组合使用。